Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · Texas

Smith + Nephew,Inc Biotherapeutics

Fort Worth, TX · ~153 workers · 3 years of OSHA Injury Tracking Application data.

C
Average Safety Record
2.8
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Smith + Nephew,Inc Biotherapeutics runs at 84% of its industry's injury rate - about level with the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade C.

Smith + Nephew,Inc Biotherapeutics: 2.8 TCR = 84% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 3y Form 300A (see methodology below)

Smith + Nephew,Inc Biotherapeutics safety composite

Smith + Nephew,Inc Biotherapeutics scores strongest on dart rate (safer than 54% of same-industry peers) and weakest on total case rate (tcr) (safer than 30%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

43/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
F 2.76 per 100 workers

Safer than 30% of industry peers

DART rate
D 0.54 per 100 workers

Safer than 54% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−6.1

2018→2023

Smith + Nephew,Inc Biotherapeutics injury rate improved

Smith + Nephew,Inc Biotherapeutics's TCR fell 6.1 from 7.2 in 2018 to 1.1 in 2023. Peak filing year was 2018 at 7.2 TCR. In 2023, DART was 0.2× this establishment's average TCR (severity share of cases).

2018=7.2 · 2021=0.0 · 2023=1.1

OSHA ITA Form 300A scorecard

Establishment book 325412 · Fort Worth, TX AT/BELOW-IND · MID

Grade C · TCR 2.8 · 84% of ind

  • DART 0.5 DART
  • RANK #25/44
  • PHOTO Colorcon Indianapolis
  • BOOK 3y book
  • INJ 11 inj
  • SIZE ~153 FTE

Nearest TCR peer: Colorcon Indianapolis (0.0 TCR gap)

Read with this employer → · Industry book → · Texas employers → · Look up another →

Smith + Nephew,Inc Biotherapeutics in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Smith + Nephew,Inc Biotherapeutics averages 2.8 TCR (84% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Smith + Nephew,Inc Biotherapeutics TCR series: 2018=7.2 · 2021=0 · 2023=1.1 · BLS 3.3

Where Smith + Nephew,Inc Biotherapeutics falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 30% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to Texas alone (the establishments it most directly competes with for workers and contracts): ranked #25 safest of 44 Pharmaceutical preparations (e employers in Texas.

Smith + Nephew,Inc Biotherapeutics (153 employees, TCR 2.8) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate Smith + Nephew,Inc Biotherapeutics
Smith + Nephew,Inc Biotherapeutics (153 employees, TCR 2.8) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

Smith + Nephew,Inc Biotherapeutics has fewer employees than the Pharmaceutical preparations (e.g., capsu median and a higher injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2023 1.1 0.5 2 0 0
2021 0.0 0.0 0 0 0
2018 7.2 1.6 9 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · TX · Fort Worth

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 38,394 rated employers in Texas with headcount on file · 1,346 employers in Fort Worth, TX · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Colorcon Indianapolis 2.8 TCR
NAICS-TCR Jarrow Industries 2.8 TCR
NAICS-TCR 464 - Pharmacy Central Fill #2 2.8 TCR
NAICS-TCR Nutra Manufacturing - Anderson Facility 2.7 TCR
STATE-SIZE San Miguel Electric Cooperative, Inc. 153 FTE
STATE-SIZE Pharr Service Center 153 FTE
STATE-SIZE Mercedes Office 153 FTE
STATE-SIZE Tri Pointe Homes Houston 153 FTE
CITY-NEAR Lockheed Martin Corporation US TX Fort Worth Lockheed Blvd (1093) 16,547 FTE
CITY-NEAR Lockheed Martin Corporation Fort Worth Campus (1093) 13,805 FTE
CITY-NEAR Cook Children's Medical Center 4,998 FTE
CITY-NEAR TX- Fort Worth 4,667 FTE
NAT-TCR Wireless - Wanamingo, MN 2.8 TCR
NAT-TCR Coeur d Alene CD 2.8 TCR
NAT-TCR Morgan's Welding LLC 2.8 TCR
NAT-TCR Julian & Sons 2.8 TCR
NAT-SIZE Encompass Health Rehabilitation Hospital of Parkersburg 153 FTE
NAT-SIZE Holy Family Medical Center 153 FTE
NAT-SIZE Case Paper Co, Inc 153 FTE
NAT-SIZE Main facility -BCI Burke Co. 153 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2023, 2021, 2018. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.